or Try an Advanced Search...

    Technical Analysis for GNPX - Genprex, Inc.

    Grade Last Price % Change Price Change
    D 2.15 -4.44% -0.10
    GNPX closed down 4.44 percent on Friday, November 1, 2024, on 37 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
    Earnings due: Nov 12
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Down Up Down
    Historical GNPX trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish 0.00%
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Wide Bands Range Expansion -4.44%
    Calm After Storm Range Contraction 6.44%
    NR7 Range Contraction 6.44%
    NR7-2 Range Contraction 6.44%
    Wide Bands Range Expansion 6.44%
    Fell Below 200 DMA Bearish -11.89%
    Calm After Storm Range Contraction -11.89%
    Older End-of-Day Signals for GNPX ...

       Recent Intraday Alerts

    Alert Time
    Down 10% about 17 hours ago
    Rose Above Previous Day's High about 20 hours ago
    200 DMA Resistance about 20 hours ago
    10 DMA Resistance about 20 hours ago
    Outside Day about 20 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    GNPX Chart by TradingView
    Basic chart:

    Profile

    Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Biology Gene Therapy Medical Genetics Applied Genetics Medicinal Chemistry

    Is GNPX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 28 Looking Into Genprex's Recent Short Interest
    Oct 28 Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer, Mesothelioma and Glioblastoma
    Oct 24 Genprex Announces Sponsored Research Agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive
    Oct 23 Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
    Oct 16 Genprex advances to highest dose in Phase I Acclaim-3 trial of Reqorsa
    Oct 15 Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer
    Sep 23 Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes
    Sep 19 Genprex Announces Formation of Mesothelioma Clinical Advisory Board
    Sep 9 Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
    Sep 4 Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes
    See more GNPX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 14.796
    52 Week Low 0.2806
    Average Volume 11,085,235
    200-Day Moving Average 2.55
    50-Day Moving Average 0.82
    20-Day Moving Average 1.35
    10-Day Moving Average 2.35
    Average True Range 0.47
    RSI (14) 59.18
    ADX 53.15
    +DI 41.36
    -DI 14.13
    Chandelier Exit (Long, 3 ATRs) 2.56
    Chandelier Exit (Short, 3 ATRs) 1.70
    Upper Bollinger Bands 3.48
    Lower Bollinger Band -0.79
    Percent B (%b) 0.69
    BandWidth 316.82
    MACD Line 0.49
    MACD Signal Line 0.41
    MACD Histogram 0.08
    Fundamentals Value
    Market Cap 3.19 Million
    Num Shares 1.49 Million
    EPS -24.40
    Price-to-Earnings (P/E) Ratio -0.09
    Price-to-Sales 0.00
    Price-to-Book 0.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.04
    Resistance 3 (R3) 3.08 2.84 2.89
    Resistance 2 (R2) 2.84 2.61 2.81 2.84
    Resistance 1 (R1) 2.49 2.47 2.37 2.45 2.79
    Pivot Point 2.25 2.25 2.19 2.22 2.25
    Support 1 (S1) 1.90 2.02 1.78 1.86 1.51
    Support 2 (S2) 1.66 1.88 1.63 1.46
    Support 3 (S3) 1.31 1.66 1.41
    Support 4 (S4) 1.27